Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
Eric A DeckersSchelto KruijffEsther BastiaannetRobert J van GinkelJosette E H M Hoekstra-WeebersHarald J HoekstraPublished in: Journal of surgical oncology (2021)
Obesity was not associated with DFI, MSS, or OS in patients with clinical stage IB-II melanoma who underwent SLNB.